Carcinogenesis, Vol. 21, No. 8, 1507-1512,
August 2000
© 2000 Oxford University Press
Cancer Biology |
Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells
Department of Medicine, University of Colorado School of Medicine and Denver Health Medical Center, 777 Bannock Street, Denver, CO 80204, USA
The RON receptor tyrosine kinase is a 180 kDa heterodimeric protein composed of a 40 kDa 
chain and a 145 kDa ß chain with intrinsic tyrosine kinase activity. Activation of RON causes cell dissociation, motility and invasion of extracellular matrices, suggesting that RON might be involved in tumor metastasis. We report here the cloning of a novel splice variant of RON in human colorectal carcinoma cell line HT-29. This RON variant is first produced as a single chain precursor with a molecular mass of 160 kDa. Proteolytic cleavage results in a 40 kDa chain and a short form of the ß chain with a molecular mass of 125 kDa. The altered receptor is synthesized from a transcript differing from the full-length RON mRNA by an in-frame deletion of 109 amino acids in the extracellular domain of the RON ß chain. The consequence of the deletion is constitutive activation of the protein with autophosphorylation. Expression of the RON variant in colon epithelial CoTr cells results in increased cell migration and invasion of extracellular matrices. These data suggest that generation of the activated splice variant of RON may contribute to the invasive phenotype of human colorectal carcinomas in vivo.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang, P. J. Kaplan-Lefko, K. Rex, Y. Yang, J. Moriguchi, T. Osgood, B. Mattson, A. Coxon, M. Reese, T.-S. Kim, et al. Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo Cancer Res., August 15, 2008; 68(16): 6680 - 6687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zhang, H.-P. Yao, and M.-H. Wang Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility Carcinogenesis, March 1, 2008; 29(3): 552 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thangasamy, J. Rogge, and S. Ammanamanchi Regulation of RON Tyrosine Kinase-mediated Invasion of Breast Cancer Cells J. Biol. Chem., February 29, 2008; 283(9): 5335 - 5343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Thomas, K. Toney, C. Fenoglio-Preiser, M. P. Revelo-Penafiel, S. R. Hingorani, D. A. Tuveson, S. E. Waltz, and A. M. Lowy The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression Cancer Res., July 1, 2007; 67(13): 6075 - 6082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Zinser, M. A. Leonis, K. Toney, P. Pathrose, M. Thobe, S. A. Kader, B. E. Peace, S. R. Beauman, M. H. Collins, and S. E. Waltz Mammary-Specific Ron Receptor Overexpression Induces Highly Metastatic Mammary Tumors Associated with {beta}-Catenin Activation Cancer Res., December 15, 2006; 66(24): 11967 - 11974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. O'Toole, K. E. Rabenau, K. Burns, D. Lu, V. Mangalampalli, P. Balderes, N. Covino, R. Bassi, M. Prewett, K. J. Gottfredsen, et al. Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Res., September 15, 2006; 66(18): 9162 - 9170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-M. Xu, Y.-Q. Zhou, and M.-H. Wang Mechanisms of Cytoplasmic {beta}-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase J. Biol. Chem., July 1, 2005; 280(26): 25087 - 25094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Camp, W. Liu, F. Fan, A. Yang, R. Somcio, and L. M. Ellis RON, a Tyrosine Kinase Receptor Involved in Tumor Progression and Metastasis Ann. Surg. Oncol., April 1, 2005; 12(4): 273 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Peace, K. Toney-Earley, M. H. Collins, and S. E. Waltz Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer Cancer Res., February 15, 2005; 65(4): 1285 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al. A proteomic study of resistance to deoxycholate-induced apoptosis Carcinogenesis, May 1, 2004; 25(5): 681 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Wang, D. Wang, and Y.-Q. Chen Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase Carcinogenesis, August 1, 2003; 24(8): 1291 - 1300. [Abstract] [Full Text] [PDF]
|
|